STORM in the News

Nature: RNA epigenetics spurs investor interest, but uncertainties linger

John Hodgson speaks to Tony Kouzarides about why RNA epigenetics is an exciting area to invest in

https://www.nature.com/articles/nbt1218-1123

SOLD OUT - RNA Epigenetics in Human Disease

A STORM Therapeutics conference | 17-20 September 2019

Find out more

Speakers

  • Reuven Agami
  • Shankar Balasubramanian
  • Thomas Carell
  • Robert Copeland
  • Tom Cech
  • Michaela Frye
  • Francois Fuks
  • Richard Gregory
  • Chuan He
  • Stacy Horner
  • Samie Jaffrey
  • Narry Kim
  • Jeannie Lee
  • Michal Minczuk
  • Gidi Rechavi
  • Tom Suzuki